CTLA4 and neoplasm: Intriguingly, many studies are now analyzing tumor stem cells as a source of immune evasion, as they have been shown to selectively acquire expression of CD80, a surface ligand that dampens immune recognition by binding Cytotoxic T lymphocyte Antigen-4 (CTLA-4) present on activated T cells [33].